CD8A and metastatic malignant neoplasm in the lymph nodes: Furthermore, an OSCC subgroup characterized by high LLT1+ TCs and low CD161+CD8+ T cells showed fewer peripheral T cells and a higher risk of lymph node metastasis, leading to a shorter 5‐year survival time (29%).